- Filed
- Mar 16, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Jan 31, 2026 | 8.48M sh |
| Shares Diluted | Q1 2026 · Jan 31, 2025 | 5.16M sh |
| Shares Outstanding | Q1 2026 · Jan 31, 2026 | 8.48M sh |
| Operating Cash Flow | Q1 2026 · Jan 31, 2026 | −$6.17K |
| Operating Cash Flow | Q1 2026 · Jan 31, 2025 | −$22.45K |
| Cash And Equivalents | Q1 2026 · Jan 31, 2026 | $2.69K |
| Cash And Equivalents | Q1 2026 · Oct 31, 2025 | $8.86K |
| Stockholders Equity | Q1 2026 · Jan 31, 2026 | $20.2K |
| Stockholders Equity | Q1 2026 · Oct 31, 2025 | $33.66K |
| Stockholders Equity | Q1 2026 · Jan 31, 2025 | −$13.31K |
| Stockholders Equity | Q1 2026 · Oct 31, 2024 | −$2.99K |
| Current Liabilities | Q1 2026 · Jan 31, 2026 | $38.02K |
| Current Liabilities | Q1 2026 · Oct 31, 2025 | $32.09K |
| Total Liabilities | Q1 2026 · Jan 31, 2026 | $130.18K |
| Total Liabilities | Q1 2026 · Oct 31, 2025 | $124.25K |
| Current Assets | Q1 2026 · Jan 31, 2026 | $3.19K |
| Current Assets | Q1 2026 · Oct 31, 2025 | $9.36K |
| Total Assets | Q1 2026 · Jan 31, 2026 | $150.38K |
| Total Assets | Q1 2026 · Oct 31, 2025 | $157.91K |
| Eps Diluted | Q1 2026 · Jan 31, 2026 | −$0.00 |
| Eps Diluted | Q1 2026 · Jan 31, 2025 | −$0.00 |
| Eps Basic | Q1 2026 · Jan 31, 2026 | −$0.00 |
| Eps Basic | Q1 2026 · Jan 31, 2025 | −$0.00 |
| Sga Expense | Q1 2026 · Jan 31, 2026 | $13.14K |
| Sga Expense | Q1 2026 · Jan 31, 2025 | $7.32K |
| Net Income | Q1 2026 · Jan 31, 2026 | −$13.45K |
| Net Income | Q1 2026 · Jan 31, 2025 | −$10.32K |
| Gross Profit | Q1 2026 · Jan 31, 2026 | $6.1K |
| Gross Profit | Q1 2026 · Jan 31, 2025 | $4.5K |
| Cost Of Revenue | Q1 2026 · Jan 31, 2026 | $4.5K |
| Cost Of Revenue | Q1 2026 · Jan 31, 2025 | $0 |
| Revenue | Q1 2026 · Jan 31, 2026 | $10.6K |
| Revenue | Q1 2026 · Jan 31, 2025 | $4.5K |